This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

ONLINE REGISTRATION CLOSES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Colby Souders PhD
Chief Scientific Officer, Biopharma at Twist Bioscience
Speaker

Profile

Colby Souders earned his PhD in Cell and Molecular Biology from Texas A&M and previously held positions at Abveris, MassBiologics and Kanyos Bio (now Anokion). At MassBiologics, he worked to advance monoclonal antibodies for the prevention, treatment or diagnosis of various infectious and endogenous diseases, as well as develop related platform technologies to advance and expand the MassBiologics pipeline. Later, he joined the Kanyos Bio Protein Engineering team to develop therapeutics based on a novel antigen-specific immune tolerance platform. Colby joined Abveris in 2018 as the Chief Scientific Officer to establish best-in-class antibody discovery workflows and build a premium discovery engine with industry-leading timelines. He has continued as Senior Director of R&D at Twist Bioscience after Abveris was acquired by Twist Bioscience in 2021.

Agenda Sessions

  • Writing the Future of Biologics with an Integrated Offering of Immunization, Libraries, and Machine Learning

    12:15pm